7th Metabolic Continuum Roundtable™ Annual Meeting

Steatotic Liver Disease (MASLD/MASH): Disease Burden – Patient Reported Outcomes – Health Economics: Payor & Societal Perspectives

November 10, 2023 | Boston, MA

The Metabolic Continuum Roundtable brings together leading experts to facilitate advances in science, clinical research, and patient care for metabolic diseases. The 7th Annual Meeting, held November 10, 2023 in Boston, facilitated a focused discussion on steatotic liver disease (MASLD/MASH), including patient outcomes, regulatory considerations, and societal and economic impacts.

Annual Meeting Topics Included:

  • Patient Burden of Disease (US/EU/World)
  • Patient Reported Outcomes / QOL
  • Health Economics  (EU/US): Societal Burden of Disease
  • Payor Market Access & Reimbursement

Moderators

Rohit-Loomba-forum-picture

Rohit Loomba, MD, MHSc

Professor of Medicine, Chief, Division of Gastroenterology and Hepatology at University of California at San Diego Director, MASLD Research Center

Arun-L-Sanyal-forum-picture

Arun J. Sanyal, MD

Z. Reno Vlahcevic Research Professor in Gastroenterology Research; Professor at Virginia Commonwealth University School of Medicine

Keynote Presenters

Zobair Younossi

Zobair Younossi, MD

Chairman and Professor of Medicine at Inova Fairfax Medical Campus

Homie Razavi

Homie Razavi, PhD, MBA

Managing Director at Center for Disease Analysis Foundation

Michael Sherman

Michael Sherman, MD, MBA, MS

Venture Partner at RA Capital Management, L.P.